---
title: "Propanc Biopharma (PPCB) soars 24% during regular trading"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/291580679.md"
description: "Propanc Biopharma jumped 24% to $1.787 in regular trading, following a 47% gain the prior day amid heightened volatility."
datetime: "2026-07-02T19:11:36.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/291580679.md)
  - [en](https://longbridge.com/en/news/291580679.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/291580679.md)
---

# Propanc Biopharma (PPCB) soars 24% during regular trading

Propanc Biopharma(PPCB.US) 盘中涨**24.10%**，现报**1.787**美元。该股前一天涨幅达 47%，近期波动加剧。

### Related Stocks

- [PPCB.US](https://longbridge.com/en/quote/PPCB.US.md)

## Related News & Research

- [Propanc Biopharma signs MOU with Avance Clinical for PRP Phase 1b trial delivery](https://longbridge.com/en/news/291933222.md)
- [Propanc Biopharma Provides Corporate Update and Reports Third Quarter 2025/26 Results | PPCB Stock News](https://longbridge.com/en/news/286567783.md)
- [Propanc Biopharma’s CEO Forecasts New Medical Breakthroughs in the Fight Against Pancreatic Cancer Over the Next Decade | PPCB Stock News](https://longbridge.com/en/news/287069272.md)
- [10:08 ETCellipont Bioservices and BobcatBio Announce Strategic Collaboration to Advance Macrophage Cell Therapy for Solid Tumors](https://longbridge.com/en/news/279448474.md)